Ignite Creation Date:
2025-12-25 @ 1:21 AM
Ignite Modification Date:
2025-12-31 @ 8:06 PM
Study NCT ID:
NCT03164993
Status:
COMPLETED
Last Update Posted:
2024-10-15
First Post:
2017-05-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Atezolizumab Combined with Immunogenic Chemotherapy in Patients with Metastatic Triple-negative Breast Cancer
Sponsor:
Oslo University Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-06-01
Start Date Type:
ACTUAL
Primary Completion Date:
2023-04-25
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-09-30
Completion Date Type:
ACTUAL
First Submit Date:
2017-05-12
First Submit QC Date:
None
Study First Post Date:
2017-05-24
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-09
Last Update Post Date:
2024-10-15
Last Update Post Date Type:
ACTUAL